The role of placebo control in clinical trials for neurodegenerative diseases

被引：0

作者：

Mehta, Arpan R. ^{[1
,2
,3
,4
,5
]}

Carpenter, James R. ^{[1
,6
]}

Nicholas, Jennifer M. ^{[1
,6
]}

Chataway, Jeremy ^{[1
,7
,8
]}

Virgo, Bruce ^{[9
]}

Parmar, Mahesh K. B. ^{[1
]}

Chandran, Siddharthan ^{[1
,2
,3
]}

Pal, Suvankar ^{[1
,10
,11
]}

机构：

[1] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, ACORD, London, England

[2] Univ Edinburgh, Euan MacDonald Ctr MND Res, Ctr Clin Brain Sci, Anne Rowling Regenerat Neurol Clin, Edinburgh, Scotland

[3] Univ Edinburgh, UK Dementia Res Inst, Edinburgh, Scotland

[4] Oxford Univ Hosp NHS Fdn Trust, Oxford, England

[5] Natl Hosp Neurol & Neurosurg, Queen Sq, London, England

[6] London Sch Hyg & Trop Med, Dept Med Stat, London, England

[7] UCL, UCL Queen Sq Inst Neurol, Fac Brain Sci, Queen Sq Multiple Sclerosis Ctr,Dept Neuroinflamma, London, England

[8] Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England

[9] Univ Edinburgh, MND SMART Patient Advisory Grp, Edinburgh, Scotland

[10] Univ Edinburgh, Euan MacDonald Ctr MND Res, Anne Rowling Regenerat Neurol Clin, Edinburgh, Scotland

[11] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Scotland

来源：

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/d41591-023-00080-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：2682 / 2683

页数：23

共 50 条